Advertisement
ResearchIn-Press PreviewHematologyImmunology
Open Access | 10.1172/JCI180913
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Tomishima, S. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Kim, D. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Porter, N. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Guha, I. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Dar, A. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Ortega-Burgos, Y. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Roof, J. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Fazelinia, H. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Spruce, L. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Thom, C. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Bowman, R. in: PubMed | Google Scholar
1Department of Pathology and Laboratory Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
2Division of Protective Immunity, Children's Hospital of Philadelphia, Philadelphia, United States of America
3Division of Cell Pathology, Children's Hospital of Philadelphia, Philadelphia, United States of America
4Division of Neonatology, Children's Hospital of Philadelphia, Philadelphia, United States of America
5Department of Cancer Biology, University of Pennsylvania Perelman School of Medicine, Philadelphia, United States of America
Find articles by Oliver, P. in: PubMed | Google Scholar
Published June 26, 2025 - More info
The balance of hematopoietic stem cell (HSC) self-renewal versus differentiation is essential to ensure long-term repopulation capacity while allowing response to events that require increased hematopoietic output. Proliferation and differentiation of HSCs and their progeny is controlled by the JAK/STAT pathway downstream of cytokine signaling. E3 ubiquitin ligases, like Cullin 5 (Cul5), can regulate JAK/STAT signaling by degrading signaling intermediates. Here we report that mice lacking Cul5 in hematopoietic cells (Cul5Vav-Cre) have increased numbers of HSPCs, splenomegaly, and extramedullary hematopoiesis. Differentiation in Cul5Vav-Cre mice is myeloid- and megakaryocyte-biased, resulting in leukocytosis, anemia and thrombocytosis. Cul5Vav-Cre mice increased HSC proliferation and circulation, associated with a decrease in CXCR4 surface expression. In bone marrow cells, we identified LRRC41 co-immunoprecipitated with CUL5, and vice versa, supporting that CRL5 forms a complex with LRRC41. We identified an accumulation of LRRC41 and STAT5 in Cul5Vav-Cre HSCs during IL-3 stimulation, supporting their regulation by Cul5. Whole cell proteome (WCP) analysis of HSPCs from Cul5Vav-Cre bone marrow identified upregulation of many STAT5 target genes and associated pathways. Finally, JAK1/2 inhibition with ruxolitinib normalized hematopoiesis in Cul5Vav-Cre mice. These studies demonstrate the function of Cul5 in HSC function, stem cell fate decisions, and regulation of IL-3 signaling.